Gene · 84464
Papers1,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastric-Type Cervical Adenocarcinoma: Clinicopathologic Features, Molecular Landscape, and Therapeutic Challenges. | J Pers Med | 2026 | 41745365 | PubTator, text mining | PubMed |
| Possible link between the apparently pathogenic FANCI variant and beneficial effects in sports performance. | Front Genet | 2026 | 41732159 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity. | Sci Adv | 2026 | 41719405 | PubTator, text mining | PubMed |
| Hemizygous loss of helicases promotes genomic instability and cancer development. | Sci Adv | 2026 | 41719398 | PubTator, text mining | PubMed |
| GWAS reveals common SLX4 variants associated with telomere length and hypertension in individuals of African ancestry. | Genes Genomics | 2026 | 41718953 | PubTator, text mining | PubMed |
| ZEB1 Promotes Alternate Lengthening of Telomeres at Multiple Levels. | Cancers (Basel) | 2026 | 41681971 | PubTator, text mining | PubMed |
| Cruciform-forming AT/TA repeats are acted upon by structure selective endonucleases and Rad51 prior to repositioning to the nuclear periphery for repair. | bioRxiv | 2026 | 41648373 | PubTator, text mining | PubMed |
| The SMC5/SMC6 complex is critical for resolving R-loop-induced transcription-replication conflicts. | Nucleic Acids Res | 2026 | 41533569 | PubTator, text mining | PubMed |
| Secoemestrin C exerts rapid and prominent anti-breast cancer effect in triple-negative breast cancer by inducing SLX4 and YAP degradation. | Acta Pharmacol Sin | 2026 | 41526650 | PubTator, text mining | PubMed |
| Tumor of Follicular Infundibulum Is Molecularly Distinct From Basal Cell Carcinoma. | Am J Dermatopathol | 2026 | 41428601 | PubTator, text mining | PubMed |
| Ginsenoside Rh2 Suppresses the Fanconi Anemia Pathway by Inhibiting NF-κB-Mediated FANCL Transcription in Bladder Cancer. | Dose Response | 2025 | 41425456 | PubTator, text mining | PubMed |
| Molecular basis of XPF-ERCC1 targeting to SLX4-dependent DNA repair pathways. | Nat Commun | 2025 | 41402316 | PubTator, text mining | PubMed |
| The BRCA1- RAD51 Axis Regulates SCAI/REV3 Dependent Replication Fork Maintenance. | bioRxiv | 2025 | 41394680 | PubTator, text mining | PubMed |
| TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer. | Dose Response | 2025 | 41346410 | PubTator, text mining | PubMed |
| Recent advances in understanding the molecular mechanisms of SLX4 recruitment in the replication stress response. | DNA Repair (Amst) | 2025 | 41337887 | PubTator, text mining | PubMed |
| CIP2A mediates mitotic recruitment of SLX4/MUS81/XPF to resolve replication stress-induced DNA lesions. | Nat Commun | 2025 | 41330930 | PubTator, text mining | PubMed |
| The CIP2A-TOPBP1 axis facilitates mitotic DNA repair via MiDAS and MMEJ. | Nat Commun | 2025 | 41309571 | PubTator, text mining | PubMed |
| Piperine Targets the FANCL/UBE2T Complex to Inhibit the FA Pathway and Sensitize Bladder Cancer to Cisplatin. | Dose Response | 2025 | 41306722 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Rare Genetic Variants in Saudi COVID-19 Patients with Extreme Phenotypes. | Viruses | 2025 | 41012626 | PubTator, text mining | PubMed |
| Mechanistic insights into alcohol-induced DNA crosslink repair by Slx4-Xpf-Ercc1 nuclease complex in the Fanconi anaemia pathway. | Commun Biol | 2025 | 41006773 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84464/papers?page=2